103 related articles for article (PubMed ID: 6891601)
41. Characterization and localization of cis-diamminedichloro-platinum(II) adducts on a purified oligonucleotide containing the codons 12 and 13 of H-ras proto-oncogene.
Pillaire MJ; Villani G; Hoffmann JS; Mazard AM; Defais M
Nucleic Acids Res; 1992 Dec; 20(24):6473-9. PubMed ID: 1480469
[TBL] [Abstract][Full Text] [Related]
42. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
Swinnen LJ; Fisher SG; Erickson LC
Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520
[TBL] [Abstract][Full Text] [Related]
43. In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication.
Ciccarelli RB; Solomon MJ; Varshavsky A; Lippard SJ
Biochemistry; 1985 Dec; 24(26):7533-40. PubMed ID: 3004558
[TBL] [Abstract][Full Text] [Related]
44. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
45. Interstrand DNA-platinum-DNA/cross-links induced by cis- and trans-diamminedichloroplatinum(II) at elevated temperature.
Kulamowicz I; Walter Z; Krupa R
Acta Biochim Pol; 1990; 37(1):77-9. PubMed ID: 2087920
[TBL] [Abstract][Full Text] [Related]
46. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]].
Lepre CA; Strothkamp KG; Lippard SJ
Biochemistry; 1987 Sep; 26(18):5651-7. PubMed ID: 3676275
[TBL] [Abstract][Full Text] [Related]
48. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).
Pinto AL; Lippard SJ
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4616-9. PubMed ID: 3895221
[TBL] [Abstract][Full Text] [Related]
49. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
Calsou P; Frit P; Salles B
Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
[TBL] [Abstract][Full Text] [Related]
50. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
[TBL] [Abstract][Full Text] [Related]
52. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
[TBL] [Abstract][Full Text] [Related]
53. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.
Andrews PA; Mann SC; Huynh HH; Albright KD
Cancer Res; 1991 Jul; 51(14):3677-81. PubMed ID: 1648442
[TBL] [Abstract][Full Text] [Related]
54. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides.
Vinje J; Intini FP; Natile G; Sletten E
Chemistry; 2004 Jul; 10(14):3569-78. PubMed ID: 15252805
[TBL] [Abstract][Full Text] [Related]
56. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
Payet D; Gaucheron F; Sip M; Leng M
Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
[TBL] [Abstract][Full Text] [Related]
57. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
Yaneva J; Leuba SH; van Holde K; Zlatanova J
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
[TBL] [Abstract][Full Text] [Related]
58. Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.
Tashiro T; Sato Y
Jpn J Cancer Res; 1992 Feb; 83(2):219-25. PubMed ID: 1556003
[TBL] [Abstract][Full Text] [Related]
59. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
